Evidence map›Paper›PMID 33532617›Full record

ArticleEndocrinology, diabetes & metabolism2021

Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global survey.

Sam N Scott, Federico Y Fontana, Thomas Züger, Markus Laimer, Christoph Stettler

Abstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Clinician, Youth, and Parent Perspectives on Diabetes Technology Education.The science of diabetes self-management and care · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Remote consultations for diabetes care in a post COVID-19 world.Diabetic medicine : a journal of the British Diabetic Association · 2023
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sam N ScottDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern Switzerland.ORCID 0000-0003-2342-9865
Federico Y FontanaTeam Novo Nordisk Professional Cycling Team Atlanta GA USA.ORCID 0000-0002-0679-6869
Thomas ZügerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern Switzerland.
Markus LaimerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern Switzerland.ORCID 0000-0002-7622-0822
Christoph StettlerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern Switzerland.ORCID 0000-0003-1691-6059

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The COVID-19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person-to-person contact is to offer remote services (telemedicine). This study aimed to (1) gather real-time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. Methods: An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open-access web-based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA Results: There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty-two per cent reported no fundamental change in their medical follow-up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty-eight per cent received remote care through telephone (72%) or video-calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA Conclusion: Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.

Indexed as

Attitude to HealthCOVID-19TelemedicineAdolescentAdultAgedDiabetes Mellitus, Type 1Disease ManagementEducational StatusFemaleGlycated HemoglobinHumansMaleMiddle AgedSARS-CoV-2Sex FactorsGlycated Hemoglobinhemoglobin A1c protein, humanCOVID‐19telemedicinetype 1 diabetes

Identifiers

PMID33532617
PMCPMC7831200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.